Tapewire

Nasdaq · USD

HRTX

HERON THERAPEUTICS, INC. /DE/

Export transactions ↓
Tapewire entity
7133
SEC CIK
0000818033
Parsed reports
288

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 13, 2022 Filed Jan 14, 2022 22:09 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003364 · doc4.xml · derivative · entry 5

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,756

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:09 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003364 · doc4.xml · derivative · entry 4

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,750

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:09 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Tax withholdingCommon Stock 2,012 $8.30 $16,699.60
Disclosure

SEC source: 0001209191-22-003364 · doc4.xml · nonDerivative · entry 3

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,783

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:09 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003364 · doc4.xml · nonDerivative · entry 2

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:09 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003364 · doc4.xml · nonDerivative · entry 1

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,231

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:08 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 16,122 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003362 · doc4.xml · derivative · entry 5

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,295

Underlying: Common Stock · 16,122 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:08 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 3,646 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003362 · doc4.xml · derivative · entry 4

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,104

Underlying: Common Stock · 3,646 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:08 UTC
Quart Barry DDirector · Chief Executive Officer
Tax withholdingCommon Stock 5,219 $8.30 $43,317.70
Disclosure

SEC source: 0001209191-22-003362 · doc4.xml · nonDerivative · entry 3

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,635

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:08 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 16,122 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003362 · doc4.xml · nonDerivative · entry 2

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:08 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,646 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003362 · doc4.xml · nonDerivative · entry 1

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:07 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003361 · doc4.xml · derivative · entry 5

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,756

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:07 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003361 · doc4.xml · derivative · entry 4

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,750

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:07 UTC
POYHONEN JOHNPresident & CCO
Tax withholdingCommon Stock 2,012 $8.30 $16,699.60
Disclosure

SEC source: 0001209191-22-003361 · doc4.xml · nonDerivative · entry 3

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,638

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:07 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003361 · doc4.xml · nonDerivative · entry 2

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:07 UTC
POYHONEN JOHNPresident & CCO
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003361 · doc4.xml · nonDerivative · entry 1

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:06 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 1,933 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003360 · doc4.xml · derivative · entry 5

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,491

Underlying: Common Stock · 1,933 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:06 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 552 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003360 · doc4.xml · derivative · entry 4

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,073

Underlying: Common Stock · 552 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:06 UTC
Peraza LisaVP, Chief Accounting Officer
Tax withholdingCommon Stock 966 $8.30 $8,017.80
Disclosure

SEC source: 0001209191-22-003360 · doc4.xml · nonDerivative · entry 3

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,716

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:06 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionCommon Stock 1,933 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003360 · doc4.xml · nonDerivative · entry 2

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:06 UTC
Peraza LisaVP, Chief Accounting Officer
Exercise / conversionCommon Stock 552 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003360 · doc4.xml · nonDerivative · entry 1

Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:05 UTC
MANHARD KIMBERLYDirector · EVP, Drug Development
Exercise / conversionRestricted Stock Units · Derivative 4,564 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003358 · doc4.xml · derivative · entry 5

MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,756

Underlying: Common Stock · 4,564 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:05 UTC
MANHARD KIMBERLYDirector · EVP, Drug Development
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003358 · doc4.xml · derivative · entry 4

MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,750

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:05 UTC
MANHARD KIMBERLYDirector · EVP, Drug Development
Tax withholdingCommon Stock 2,012 $8.30 $16,699.60
Disclosure

SEC source: 0001209191-22-003358 · doc4.xml · nonDerivative · entry 3

MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,070

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:05 UTC
MANHARD KIMBERLYDirector · EVP, Drug Development
Exercise / conversionCommon Stock 4,564 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003358 · doc4.xml · nonDerivative · entry 2

MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,082

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 22:05 UTC
MANHARD KIMBERLYDirector · EVP, Drug Development
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-003358 · doc4.xml · nonDerivative · entry 1

MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 18:58 UTC GrantStock Option (Right to Buy) · Derivative 20,903 $0.00 Strike: $9.81 $0.00
Disclosure

SEC source: 0001209191-21-071170 · doc4.xml · derivative · entry 2

Rodriguez Susan · CIK 0001812511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,903

Underlying: Common Stock · 20,903 shares

Expires 2031-12-22

F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 18:58 UTC GrantCommon Stock 10,452 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-071170 · doc4.xml · nonDerivative · entry 1

Rodriguez Susan · CIK 0001812511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,702

F1 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:58 UTC GrantStock Option (Right to Buy) · Derivative 20,903 $0.00 Strike: $9.81 $0.00
Disclosure

SEC source: 0001209191-21-071172 · doc4.xml · derivative · entry 3

Christian Waage · CIK 0001553179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,903

Underlying: Common Stock · 20,903 shares

Expires 2031-12-22

F4 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:58 UTC GrantCommon Stock 10,452 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-071172 · doc4.xml · nonDerivative · entry 2

Christian Waage · CIK 0001553179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,652

F3 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:56 UTC GrantStock Option (Right to Buy) · Derivative 20,903 $0.00 Strike: $9.81 $0.00
Disclosure

SEC source: 0001209191-21-071168 · doc4.xml · derivative · entry 2

Dissanaike Sharmila · CIK 0001885069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,903

Underlying: Common Stock · 20,903 shares

Expires 2031-12-22

F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:56 UTC GrantCommon Stock 10,452 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-071168 · doc4.xml · nonDerivative · entry 1

Dissanaike Sharmila · CIK 0001885069 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,702

F1 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:57 UTC GrantStock Option (Right to Buy) · Derivative 20,903 $0.00 Strike: $9.81 $0.00
Disclosure

SEC source: 0001209191-21-071169 · doc4.xml · derivative · entry 3

Johnson Craig A · CIK 0001370348 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,903

Underlying: Common Stock · 20,903 shares

Expires 2031-12-22

F4 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:57 UTC GrantCommon Stock 10,452 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-071169 · doc4.xml · nonDerivative · entry 2

Johnson Craig A · CIK 0001370348 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,292

F3 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:55 UTC GrantStock Option (Right to Buy) · Derivative 20,903 $0.00 Strike: $9.81 $0.00
Disclosure

SEC source: 0001209191-21-071167 · doc4.xml · derivative · entry 2

DAVIS STEPHEN · CIK 0001131146 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,903

Underlying: Common Stock · 20,903 shares

Expires 2031-12-22

F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.

Read SEC document
December 22, 2021 Filed Dec 23, 2021 23:55 UTC GrantCommon Stock 10,452 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-071167 · doc4.xml · nonDerivative · entry 1

DAVIS STEPHEN · CIK 0001131146 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,452

F1 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022.

Read SEC document
December 21, 2021 Filed Dec 23, 2021 23:58 UTC SaleCommon Stock 300 $9.73 $2,920.35
Disclosure

SEC source: 0001209191-21-071172 · doc4.xml · nonDerivative · entry 1

Christian Waage · CIK 0001553179 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,200

F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021.

F2 · price: The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

Read SEC document
December 21, 2021 Filed Dec 23, 2021 23:57 UTC SaleCommon Stock 250 $9.73 $2,431.93
Disclosure

SEC source: 0001209191-21-071169 · doc4.xml · nonDerivative · entry 1

Johnson Craig A · CIK 0001370348 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,840

F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 3, 2021. The shares were sold by Mr. Johnson to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021.

F2 · price: The range of sales prices received was $9.625 to $9.845. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

Read SEC document
October 29, 2021 Filed Dec 23, 2021 23:59 UTC
POYHONEN JOHNPresident & CCO
OtherCommon Stock 817 $9.36 $7,645.89
Disclosure

SEC source: 0001209191-21-071173 · doc4.xml · nonDerivative · entry 1

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,836

F1 · kind: Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 29, 2021.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:25 UTC
Quart Barry DDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 195,417 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060551 · doc4.xml · derivative · entry 5

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,417

Underlying: Common Stock · 195,417 shares

Expires not disclosed

F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:25 UTC
Quart Barry DDirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 390,834 $0.00 Strike: $10.55 $0.00
Disclosure

SEC source: 0001209191-21-060551 · doc4.xml · derivative · entry 4

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 390,834

Underlying: Common Stock · 390,834 shares

Expires 2031-10-13

F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:25 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 3,646 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060551 · doc4.xml · derivative · entry 3

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,750

Underlying: Common Stock · 3,646 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:25 UTC
Quart Barry DDirector · Chief Executive Officer
Tax withholdingCommon Stock 963 $10.55 $10,159.65
Disclosure

SEC source: 0001209191-21-060551 · doc4.xml · nonDerivative · entry 2

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,086

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:25 UTC
Quart Barry DDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,646 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-060551 · doc4.xml · nonDerivative · entry 1

Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:26 UTC
Szekeres David LeslieEVP, Chief Operating Officer
GrantRestricted Stock Units · Derivative 55,320 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060553 · doc4.xml · derivative · entry 5

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,320

Underlying: Common Stock · 55,320 shares

Expires not disclosed

F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:26 UTC
Szekeres David LeslieEVP, Chief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 92,200 $0.00 Strike: $10.55 $0.00
Disclosure

SEC source: 0001209191-21-060553 · doc4.xml · derivative · entry 4

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,200

Underlying: Common Stock · 92,200 shares

Expires 2031-10-13

F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:26 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060553 · doc4.xml · derivative · entry 3

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:26 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Tax withholdingCommon Stock 433 $10.55 $4,568.15
Disclosure

SEC source: 0001209191-21-060553 · doc4.xml · nonDerivative · entry 2

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,981

F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:26 UTC
Szekeres David LeslieEVP, Chief Operating Officer
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-060553 · doc4.xml · nonDerivative · entry 1

Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:24 UTC
POYHONEN JOHNPresident & CCO
GrantRestricted Stock Units · Derivative 55,320 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-060550 · doc4.xml · derivative · entry 5

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,320

Underlying: Common Stock · 55,320 shares

Expires not disclosed

F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 20:24 UTC
POYHONEN JOHNPresident & CCO
GrantEmployee Stock Option (Right to Buy) · Derivative 92,200 $0.00 Strike: $10.55 $0.00
Disclosure

SEC source: 0001209191-21-060550 · doc4.xml · derivative · entry 4

POYHONEN JOHN · CIK 0001286100 · President & CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,200

Underlying: Common Stock · 92,200 shares

Expires 2031-10-13

F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.